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A kinetic analysis
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Administration Hospital, Philadelphia, Pennsylvania
Disposition of intravenous potassium in anuric man: A kinetic
analysis. The disposition of a constant-rate (0.3 mEq/kg/hr) intra-
venous potassium load was studied in anuric, chronic hemo-
dialysis patients. Changes in plasma potassium concentration
could be adequately described by a two-compartment kinetic
model under both isohydric conditions and during acute metabol-
ic alkalosis. From 63 to 92% of the infused potassium left the
extracellular fluid (ECF) in isohydric studies, and from 73 to 97%
left the ECF in alkalanizing studies. Cellular uptake of the in-
fused potassium was less when the plasma potassium concentra-
tion was higher. Plasma aldosterone levels rose but insulin levels
did not increase during infusions. In a juvenile-onset diabetic
subject, the impairment of cellular potassium uptake at higher
plasma potassium was magnified so that infused potassium was
virtually confined to the ECF compartment until exogenous in-
sulin was given. This implies a permissive rather than a regula-
tory role for endogenous insulin in facilitating cellular entry of
excess potassium.
Disposition du potassium intraveineux chez l'bomme anurique:
Une analyse cinétique. La disposition d'une charge intraveineuse
de potassium a debit constant (0,3 mEq/kglhr) a été étudiée chez
des malades anuriques en hémodialyse chronique. Les modifica-
tions de Ia kaliémie peuvent être décrites de facon satisfaisante
par un modèle cinetique a deux compartiments aussi bien dans
des conditions d'isohydrie que d'alcalose metabolique aiguë. Dc
63 a 92% du potassium perfuse quitte le liquide extracellulaire
(ECF) dans les etudes en isohydrie, et de 73 a 97% dans celles en
alcalose. La captation cellulaire du potassium perfuse est nor-
male quand Ia concentration plasmatique est élevée.
L'aldostéronémie augmente, mais non l'insulinémie, au cours
des perfusions. Chez un sujet atteint de diabète d'installation
juvenile, l'altération de Ia captation cellulaire de potassium aux
kaliemies élevées était augmentee de telle sorte que Ic potassium
perfuse était pratiquement confine dans Ic compartiment ECF
jusqu'à ce que de l'insuline exogène soit administrée, Ccci im-
plique un rOle plutOt permissif que regulateur de l'insulinc en-
dogene dans Ia facilitation de l'entrée cellulaire du potassium en
excés.
When potassium enters the body, the change that
occurs in the plasma potassium concentration (PK)
is determined by the balance between the rate of
potassium entry into the extracellular fluid (ECF)
and its rate of exit via the processes of renal excre-
tion and cellular uptake. It is generally acknowl-
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edged that before an adaptive increase in renal po-
tassium excretion occurs, there is some degree of
cellular uptake of an acute potassium load [1, 2].
There has been, however, relatively little investiga-
tion into either the capacity or control of this pro-
cess.
To explore the dynamics of cellular potassium
uptake in human subjects, we studied the dis-
position of an acute intravenous potassium load in
chronic stable hemodialysis patients. In these virtu-
ally anuric subjects, changes in PK clearly reflect the
distribution of administered potassium between
body fluid compartments. Kinetic analysis of the
data was used to quantify the rapidity and extent of
cellular potassium uptake. In these unique observa-
tions in human subjects, the following questions
were considered: (1) Do prior alterations in external
potassium balance modify cellular uptake of acute
potassium loads? (2) Can potassium entry into cells
be described by a simple first-order kinetic model,
or is a more complex (for example, saturable) model
required? (3) Do acute increases in blood pH affect
the kinetics of potassium distribution? (4) What
roles are played by endogenous hormone secretion
(insulin and aldosterone) in the physiologic control
of potassium uptake by cells?
Methods
Each of five, male, virtually anuric patients with
end-stage renal disease on chronic hemodialysis
participated in two to five studies for a total of 19
studies (Tables 1 and 2). Informed consent was ob-
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Table 1. Results of isohydric infusionsa
Study
no.
P50
mEq/liter
t
mm
Static parameters
- ------ Kinetic parameters
mEqiliter mEq/liter
Percent
t
exit
ss
aVD,
liter/kg
aVD5
liter/kg
Jmax
%R
k1
min' k2min1 t'/2mm
A2 3.69 150 1.56 1.17 58.4 68.8 0.64 0.68 70.5 0.030 0.013 16.2
A3 4.05 150 1.60 1.05 57.3 71.8 0.71 0.66 69.9 0.027 0.012 18.1
Al 4.65 150 1.93 1.26 48.4 67.7 0.60 0.55 63.3 0.018 0.011 24.4
Bi 2.69 180 1.31 0.65 70.9 85.5 1.38 1.22 83.6 0.027 0.005 21.7
B3 3.54 180 1.70 1.13 62.2 75.0 0.80 0.82 75.6 0.025 0,008 21.3
B2 3.76 180 1.59 0.80 64.7 82.3 1.13 1.03 80.6 0.027 0.006 21.1
B4 4.05 180 2.19 1.21 51.3 73.0 0.74 0.71 71.7 0.016 0.006 30.5
Cl 3.72 135h
180
Ø,83b
1.07 0.34
754b
76.2 92.4 2.65 1.89 89.4
.
0.039
.
0.005
..
16.0
C2
C3
3.78
4.18
135b
180
135
102b
1.15
1.86
0.51
1.00
698b
74.4
44.9
88.6
63.3
1.76
0.55
1.34
0.55
85.0
63.3
0.038
0.016
0.007
0.009
15.5
27.6
D3 3.81 180 1.26 0.63 72.0 86.0 1.43 1.27 86.4 0.030 0.005 20.1
D2 3.85 180 1.42 0.65 68.4 85.5 1.38 1.09 81.7 0.027 0.006 20.1
DI 4.12 180 1.43 0.65 68.2 85.5 1.38 1.16 82.8 0.025 0.005 22.9
El
E2
3.39
4.23
150"
180
150
127"
1.29
3.19
1.14
3.260
66b
71.3
14.9
75.7
13.0
0.79
0.23c
0.84 76.1
....
0.048 0.015 11.1
a Studies are listed in order of increasing preinfusion plasma potassium concentration (P50). Capital letters indicate the subject studied
and numerals the study sequence in that subject. Abbreviations are defined as t, duration of infusion; APK,, increment in plasma
potassium concentration (PK) above P5 at time t; APK, increment in P5 above P 2 hours after discontinuation of infusion; percent exit,
percent of infused potassium which has left an assumed extracellular volume of 0.2 liter/kg at the end of infusion (t) or 2 hours after
discontinuation of infusion (ss); aVD,, apparent volume of distribution of infused potassium computed from the amount of potassium
infused and P5,,; aVD5, apparent volume of distribution of infused potassium from kinetic analysis; k, and k2, kinetic rate constants
(Fig. 1); Viz, distribution half-life; Jmax, maximum net flux from compartment Ito 2, expressed as a percent of the infusion rate (%R).
b To allow intrasubject comparisons in those subjects in whom the infusion duration was shortened in any one study, we have given
values for P5 and % exit for the time of the shortest study in that subject.
Value was computed from mean APK during 40 mm of observation postinfusion.
tamed from each patient. All patients were allowed
their usual diets during the period between studies.
Patient E was a juvenile-onset, insulin-requiring
diabetic; the other patients were not diabetics.
None of the patients had congestive heart failure,
edema, severe hypocalcemia, or changes in "dry
weight" throughout the study.
Following a routine 5- to 6-hour hemodialysis, the
patients were fasted for 10 hours overnight and
studied the next morning (approximately 18 hours
after hemodialysis). Patient E received only his usu-
al morning dose of NPH insulin (20 U) 24 hours
prior to the study.
Heparinized blood samples were obtained via a
standard 14-gauge dialysis needle in the patient's ar-
teriovenous fistula. Samples were immediately cen-
trifuged, and plasma was separated for determina-
tions of: PK and plasma sodium concentration by
flame photometry (Instmmentation Laboratories
443); immunoreactive insulin (IRI) by a solid-phase
antibody method (Phadebus®); and aldosterone by
radioimmunoassay (Dr. R. Underwood, Boston,
Massachusetts [3]). Determinations of pH and Pco2
were made on whole blood (Radiometer Copenha-
gen PHM 71 electrode). Plasma bicarbonate con-
centration was either calculated from the Hender-
Table 2. Results of alkalinizing infusions"
Study
no.
P50
mEq/liter
t
mm ApH
LHCO3
mEq/liter
Perce
t
nt exit
ss
aVD,
liters/kg
aVD,,
liters/kg
Jmax
%R
Aa 4.31 150 0,09 5.9 57.3 72.5 0.72 0.64 69.0
Ab 4.32 150 0.09 4.2 60.5 73.9 0.76 0.74 73.0
B 3.21 180 0.07 5.8 78.7 90.9 2.31 2.29 91.3
C 3.81 180 0.05 4.8 81.6 97.1 6.92 8.45 97.6
a Capital letters represent same subjects as in Table 1, lower case letters the sequence of the two studies in A. ApH and AHCO3 are the
increment in pH and plasma [HCO3] over preinfusion values at 2 hours postinfusion. Other abbreviations are defined in Table 1.
Disposition of potassium in anuric man 653
son-Hasselbalch equation or estimated by measure-
ment of pH and total plasma carbon dioxide
concentration (Natelson microgassometer).
The studies consisted of a constant-rate infusion
(Sigmamotor 4200 pump) of potassium (0.3 mEq/kg
body weight per hour) in a peripheral vein following
30 mm of baseline determinations. In most studies,
an isohydric infusate was used, which contained (in
mEq/liter): potassium, 60; sodium, 94; chloride,
132; and bicarbonate, 22. In a small number of stud-
ies, an alkalinizing infusate was used, which con-
tained (in mEq!liter): potassium, 60; sodium, 94;
bicarbonate, 154.
Safety was insured by a physician's constant at-
tendance, 12-lead electrocardiographic monitor-
ing, and bedside PK measurements every 15 mm
throughout the infusion. Infusions never exceeded
180 mm, but were terminated earlier if PK reached
6.5 mEq!liter, even if no electrocardiographic signs
of hyperkalemia appeared. Plasma samplings and
measurements continued for 2 hours after stopping
the infusions. Blood pH and Pco2 were determined
at the beginning and end of all infusions. Following
completion of the studies, patients were dialyzed.
To assess the influence of body potassium stores
on the disposition of infused potassium, we varied
the dialysate potassium concentration in each pa-
tient for 1 to 4 weeks prior to study, resulting in
varying levels of preinfusion PK (PK0; Table 1).
In subject B, who had a urine output of 300 ml!
day, urinary potassium losses were determined to
be less than 6 mEq throughout a study and were
ignored. In the other subjects, who had urine out-
puts of less than 60 ml/day, urinary potassium
losses were not determined. Stool potassium losses
were not measured, but no patient formed more
than one solid stool per day.
Kinetic analysis. A closed two-compartment
model with first-order kinetics and bidirectional flux
between compartments was the simplest kinetic
model able to explain the observed changes in PK
(Fig. 1). Compartment 1 was assumed to represent
ECF, and the potassium concentration in this com-
partment was assumed to equal PK, since there is
known to be a nearly immediate (within seconds)
distribution of potassium in ECF [4]. In this model,
the change in the amount of potassium in com-
partment 1 (X1) during the infusion is described by
the equation:
dX1/dt = k2X2 — k1X1 + R
After stopping the infusion,
dX1/dt = k2X2 — k1X1
The change in the amount of potassium in com-
partment 2 (X2) is:
dX2/dt = k1X1 — k2X2 (3)
X1 and X2 (mEq/kg of body weight) are the quan-
tities of potassium in compartments I and 2, respec-
tively; R (mEq!kg/min) is the rate of potassium in-
fusion; and k1 and k2 are rate constants (mint).
By definition, at steady state, there is no net flux
between compartments: k1X1 — k2X2 = 0. There-
fore, k1X1 = k2X2. Also by definition, potassium
concentrations in the compartments are equal at
steady state: X1/V1 = X2/VZ (where V1 and V2 are
the volumes [liters/kg] of compartments 1 and 2, re-
spectively). By substitution: V2 = V1 (k1/k2). V1
(and ECF) was assumed to be 0.2 liter/kg body
weight. Thus, V2 = 0.2 (k1/k2).
The kinetically determined apparent volume of
distribution for infused potassium (aVDk) equals the
sum of V1 and V2. The half-life (tV2) for potassium
distribution equals 0.693!(k1 + k2).
Equations 1 and 3, or 2 and 3, were integrated
numerically with a digital computer under control of
an optimization routine that minimized the sum of
squared deviations of the calculated curve from the
observed data [5, 6]. The data from each study dur-
ing and after infusion were simultaneously fit by a
regression curve described by equations 1, 2, and 3
and solved for the kinetic parameters k1 and k2.
From these values the aVDk and t'/2 then were cal-
culated.
For simplicity, changes in V1 during the infusions
have been ignored, since, at most, such changes
would equal the infusion rate (at 0.005 liter/kg/hr,
the longest infusion would produce a 7% increase in
the initial V1 of 0.2 liter/kg). Considering the rela-
tive uncertainty of the actual size of ECF [7], this
error is negligible.
The first-order kinetic model presented (Fig. 1) is
called "linear" because k1 remains constant, and
unidirectional potassium flux from compartment I
to compartment 2 (k1X1) increases linearly with in-
creasing PK. If instead, k1 is made a declining func-
tion of PK (k1 = a — /3 [PK]), as PK rises, the product
k1X1 increases at a progressively diminishing rate,
passes through a maximum, and then declines. The
computer solution of this "nonlinear model" yields
values for a and /3. The values of a and /3 that fit
these data were such that the maximum k1X1 oc-
curred at close to the highest PK achieved, and
(1) hence the model approximately mimicked a satu-
rable process.
Statistical methods. Data are expressed as mean
(2) SEM or as ranges. Except where otherwise stated,
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A
_______
x2
Fig. 1. Distribution of potassium between two closed com-
partments. R is the rate of infusion into compartment 1. X1 and
X2 represent the amounts of potassium in compartments 1 and 2,
respectively. k1 and k2 are kinetic rate constants of potassium
transfer between the two compartments, in the direction shown
by the arrows.
probability was determined by a two-sided Student
t test for paired variables. To test the association of
the variable PK0 with each of several parameters, we
used Kendall's 'r technique [8]. This nonparametric
technique, in r is similar to a correlation coef-
ficient but depends only on ranks, allows separate
computation for each subject, and hence, a better
control for intersubject variability. A combined sig-
nificance level is then computed over all subjects
and is based on the exact distribution of r.
Results
All patients tolerated the studies well with no ill
effects. Electrocardiographic changes, limited to
peaking of precordial T waves, occurred only in
studies C3 and E2 and dictated termination of the
infusions. In study E2, the peak PK exceeded the
limits set in the protocol because of the unexpect-
edly precipitous rise in PK; the patient was treated
with 10 U of regular insulin s.c., and hemodialysis
was instituted shortly thereafter.
A typical experiment is illustrated in Fig. 2 (top
panel). At any time, the increment in PK from its
preinfusion level is expressed as XPK. If all infused
potassium were to be confined to an ECF volume of
0.2 liter/kg, the PK would be the milliequivalents
per kilogram of potassium infused divided by 0.2 li-
ter/kg. In each study (except E2), the observed LPK
deviated progressively from that predicted from
ECF distribution, representing an accelerating net
potassium exit from ECF. The percentage of in-
fused potassium that had left the ECF (percent exit)
can be calculated from the deviation of each ob-
served LPK from the LPK which would have oc-
curred with ECF distribution alone.
/
Percent exit = 100 x I I — ______________\ K infused/O.2
By the end of the infusion, the percent exit ranged
from 44.8% to 76.2% (Table 1, isohydric studies).
In all studies except E2, when the infusion
stopped, PK fell, representing a continuing net exit
of potassium from ECF (Fig. 2, top panel). The ini-
tial rapid fall in PK progressively slowed as PK ap-
proached a steady-state level by 2 hours after the
infusion, at which time the percent exit ranged from
63.7% to 92.4%.
A static measure of the apparent volume of distri-
bution of infused potassium (aVD5) can be made by
taking the amount of potassium infused and dividing
by LPK at steady state (PK) (the latter is approxi-
mated by PK at 2 hours postinfusion): aVD5 =
infused LPKSS. In the isohydric studies (excluding
study E2, which did not extend for 2 hours post-
Time, rn/n
Time, mm
Fig. 2, TopA typical study. is the increment in plasma potas-
skim concentration from preinfusion level. The line labeled
"ECF distribution" represents the expected AP5 if all infused
potassium were confined to an ECF volume of 0.2 liter/kg of
body weight. Bottom Characteristics of the linear kinetic model.
The slope of the linear portion of the rising phase (after 90 mm) of
the curve (dPK/dt) is predictive of the steady-state .PK at the end
of the falling phase of the curve Jm.x and t are defined in
Table 1.
E
C-
' 0.5
180
0 60 120
Infusion - .—Postinfusion—
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infusion), aVD0 was 1.14 0.15 liters/kg with a
range of 0.55 to 2.65 liters/kg (Table 1).
The parameters percent exit and aVD0 are deter-
mined from single data points and are subject to the
error of individual measurements. They will be re-
ferred to as "static parameters." Parameters gener-
ated by the kinetic model, which provides a regres-
sion curve fit to all the data points, will be referred
to as "kinetic parameters."
The regression line described by equations 1, 2,
and 3 for the two-compartment linear kinetic model
(Fig. 2, top panel) is curvilinear, since net outfiux
from the ECF increases during the infusion and
asymptotically approaches a limit (Jmax, Appendix).
Since net flux reaches 94% of its maximum after four
distribution t1/2s, the subsequent rate of potassium
exit from ECF becomes essentially constant, and
the rise of PR becomes nearly linear. When the in-
fusion stops, net flux out of ECF falls exponentially
toward zero, so that in another four t1/2S, return of PR
to a new steady state level is 94% complete. In the
14 isohydric studies evaluated by the linear model,
V!2 was 20.4 1.4 mm, and imax ranged from 63.4%
to 89.4% of the infusion rate. The aVDk was 0.99
0.10 liter/kg (ranging from 0.54 to 1.89 liters/kg and
not statistically different from aVD0).
For the kinetic analysis, V1 was assumed to be
0.2 liter/kg. Based on this assumption, if no potas-
sium left the ECF, the calculated LPK after 15 mm
of infusion would be 0.38 mEq/liter. The observed
PK at 15 mm (the earliest measurement) in the 19
studies was 0.34 0.02 mEq/liter. The difference
between these values represents a loss of 10% of the
infused potassium from a volume of 0.2 liter/kg, an
amount consistent with the observed rates of potas-
sium distribution. Thus, the assumed volume fits
the findings well.
As shown in Fig. 2 (bottom panel), and Appendix
2, the model predicts that the rate of rise in PK in the
linear portion of the curve during infusion will de-
termine the total amount of infused potassium to
leave the ECF. A comparison of the observed PKSS
and that predicted from the slope of the linear por-
tion of the curve (as determined by a simple linear
regression) provides a test of the validity of the
model, which is independent of any assumptions
about the size of compartment I. Of the 14 isohy-
dric studies (excluding E2 which did not have a lin-
ear portion), the "predicted" and observed values
agreed closely in 11(0.86 0.07 vs. 0.78 0.08
mEq/liter). In the remaining 3 studies (Al, B4, and
C3), the "predicted" value was markedly higher
than the observed values were (by 0.58, 1.00, and
1.01 mEq/liter), and their fit by the linear kinetic
model was relatively poor, as discussed below.
Alternative methods of determining the "good-
ness of fit" of the model to the data are: (1) quan-
titation of the deviation (SD) of data points from the
regression curve; and (2) visual inspection for sys-
tematic deviation of the curve from the data. In gen-
eral, the curve for the simple linear model showed
little quantitative or visual deviation from the data
(mean SD of PK about the regression curve was 0.077
mEq/liter, with a range of 0.051 to 0.115 mEq/liter).
Visual inspection revealed systematic deviation of
the regression curves from the observed data only
in studies Al, B4, and C3; these studies all had a
PR0 greater than 4 mEq/liter and had the highest SD
of PR about the regression. In these three studies,
there was better visual and quantitative fit by the
nonlinear model (See Methods and Fig. 3).
Effect of preinfusion plasma potassium (PK). The
data for the isohydric studies are presented in Table
1. In a given subject, the disposition of the same
potassium load can be seen to be markedly altered
when PK is either raised or lowered via manipula-
tions of external potassium balance; a higher PR0
was correlated with a diminished rate of exit of po-
tassium from the ECF.
The relationship between PR0 and the static and
kinetic parameters in each subject is shown in Fig.
4. The association of PR and these parameters was
tested in a nonparametric manner (Kendall's r test
[8]). PR0 is significantly (P < 0.05) associated to per-
cent exit, k1, and the Jmax (and to aVDk, which is
another mathematic expression of Jmax [Appendix]).
2.0
0 60 120o 60 120
Time, rn/n
Fig. 3. Improved fit of data from study C3 by the nonlinear mod-
el. The dotted line represents the curve described by the linear
model; the solid line represents the curve described by the non-
linear model (see text). .PK is defined in Fig. 2.
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Fig. 4. Association between the preinfusion plasma potassium concentration (P5) and the pa-
rameters describing potassium flux out of the ECF. k1, Jmx, percent exit are defined in Table 1.
aVD refers to the static apparent volume of distribution (aVD in Table 1).
The studies in the diabetic subject are excluded
from this analysis; if included, they would serve to
reinforce the conclusions. Changes in body weight,
blood pH, bicarbonate, and plasma sodium concen-
tration were small in magnitude and inconsistent in
direction.
The tendency for a lower k1 in studies with higher
PK (Fig. 4, top panel) was mirrored by the improved
fit of the data from single studies by the nonlinear
model (since this model assumes that k1 falls during
infusion as PK rises) (Fig. 3). By applying this mod-
el, the SD of PK about the regression curve was im-
proved in 11 of the 13 isohydric studies of non-
diabetic subjects, most remarkably in the 5 studies
in which K was greater than 4 mEq/liter.
Effect of alkalinization. As expected, in the
isohydric infusions, preinfusion and postinfusion
arterial pH (7.38 0.01 and 7.38 0.02, respective-
ly) and bicarbonate (22.0 0.7 and 21.3 0.7 mEqI
liter, respectively) differed little. With alkalinizing
infusions, plasma bicarbonate progressively in-
creased from 21.7 0.6 mEq/liter preinfusion to
27.9 0.4 mEq/liter at the end of infusion, and then
fell to 26.9 0.4 mEq/liter 1 to 2 hours post-
infusion; corresponding pH values were 7.40
0.02, 7.50 0.01, and 7.47 0.01. Despite the pro-
gressively increasing alkalosis, the fit by the kinetic
model was excellent, (SD of PK about the regression
curve ranged from 0.053 to 0.079 mEq/liter). Potas-
sium exit from the ECF was enhanced by alkaliniza-
tion, as shown by both kinetic and static parameters
(Table 2).
Potassium tolerance in the diabetic subject. In
the diabetic subject, the tendency for decreased po-
tassium tolerance with higher PK0 was much more
exaggerated, and was unexplained by differences in
body weight, blood glucose, pH, bicarbonate, or
plasma sodium concentration between the high and
low PK0 studies. At a PK0 of 3.4 mEq/liter (study El),
the findings in this subject were very similar to the
0.04—
P = 0.004
0.021—
90
P=0.020
___
K0' mEq//iter
3
P = 0.086
x
C
a) 60
50'
40'
I I I I
3 4
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eight studies in nondiabetics in which PK was less
than 4 mEq/liter (mean, 3.6 mEq/liter) (Fig. 5). At a
PK of4.2 mEq/liter (study E2), however, PK rose far
more rapidly than it did in any other study (Table 1,
Fig. 5), and, contrary to all other studies, it failed to
fall following the infusion. Thus, infused potassium
appeared to be virtually confined to the ECF. (The
aVD calculated from the mean postinfusion PK prior
to insulin was 0.23 liter/kg.) Ten minutes after sub-
cutaneous administration of 10 U of regular insulin,
PK fell rapidly without any change in blood glucose.
The linear kinetic model fit the data obtained in
study El well with kinetic parameters similar to
those derived from studies in nondiabetics (Table
1). There was no improvement in fit by application
of the nonlinear model. Since the data from study
E2 clearly showed an increasing rather than a de-
creasing rate of rise in PK during infusion (Fig. 5),
the linear model could not be applied, nor could any
satisfactory fit of the data be obtained by applying
the nonlinear model.
Role of endogenous insulin. Immunoreactive in-
sulin (IRI) levels were measured in all nondiabetic
subjects, and did not rise in either isohydric or a!-
kalinizing studies when PK was increasing. In the 17
studies, preinfusion IRI was 17.4 1.3 sU/ml; at
the end of the infusions (when PK had increased 1.5
0.1 mEq/liter), IRI was 16.8 1.8 pU/ml.
Role of endogenous aldosterone. In contrast to
IRI, plasma aldosterone levels rose in nondiabetics
during eight of the nine isohydric infusions in which
it was measured. By the end of infusion, aldoste-
rone levels (27.4 5.1 ng/l00 ml) were nearly
double the preinfusion levels (14.8 3.1 ng'lOO ml)
(P < 0.05). Two hours postinfusion, plasma aldoste-
rone had fallen to about half the preinfusion levels
(P < 0.05). In the diabetic subject, preinfusion and
postinfusion aldosterone levels were lower (< 4 ng/
100 ml), and there was little or no rise in aldosterone
levels during infusion or, in study E2, after insulin
administration.
Plasma aldosterone levels rose by about 40% in
the first 15 mm of the alkalinizing infusions, but
then fell in three of the four studies, so that mean
plasma aldosterone at the end of the infusion (6.2
1.2 ng/100 ml) was less than half the preinfusion lev-
els (13.4 4.4 ng/100 ml).
Discussion
Relatively little is known of the capacity of the
intracellular compartment to absorb potassium or of
the factors controlling the process. This can be
studied by administering potassium when there is
no renal potassium excretion. In two recent studies
[9, 10], potassium infused into nephrectomized ani-
mals caused changes in P which were similar to
4
3
2
8
a.
a
C
a,
8
C)C
4
3
2
I I I I
'0 60 120 180 240 300 Th 60 120 180 240
Time, mm
Fig. 5. Potassium distribution in the diabetic subject. The left panel depicts study El at PK0 =
3.4 mEq/liter, and the right panel depicts study E2 at = 4.2 mEq/liter (see Table 1). The
shaded areas represent the entire range of values in nondiabetic subjects studied at P0 less than
4 mEq/liter tleft) and PK0 greater than 4 mEq/liter fright). Arrow 1 represents the point at which
the infusions were stopped. Arrow 2 represents the point at which exogenous insulin was admin-
istered.
300
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those of the present study in humans. The apparent
volume of distribution as determined from the post-
infusion PK was also similar: 1.22 liters/kg [9] and
1.16 liters/kg [10] versus 1.14 liters/kg in our study.
In one of these studies, the disposition of the in-
fused potassium was analyzed with a linear kinetic
model [9]. The model, however, did not allow for
backflux from the intracellular fluid; thus an ex-
ponential fall in PK to the original preinfusion levels
was predicted after cessation of the infusion (im-
plying an infinite volume of distribution for the in-
fused potassium). Although the model fit the data
during potassium infusion, there were marked de-
viations of the postinfusion data. The present model
assumes bidirectional flux between compartments
and, rather, predicts an exponential fall in PK to a
new steady state level postinfusion.
The linear kinetic model used in the present study
requires the kinetic rate constants to remain inde-
pendent of any changes in the potassium concentra-
tion in either compartment. Separate studies of
single subjects, however, showed dependence of k1
on PK. In addition, in some individual studies, the
fit by a nonlinear model was better than the linear
model was, raising questions as to the validity of the
latter. Given the duration of these studies, how-
ever, the linear model proved to be adequate, in
particular when PK was low (and the increment in
PK during infusion small). In its simplicity, the linear
kinetic model is useful because (1) it fits the ob-
served data in the usual setting for potassium thera-
py (that is, hypokalemia); (2) it does not require a
computer, since it predicts that the rate of rise in PK
during potassium infusion will eventually become
constant; this easily measurable rate will predict the
ultimate distribution of infused potassium after
equilibration occurs, that is, the ultimate PK (Fig. 2,
bottom panel). Therefore, no attempt was made to
apply more complex multicompartmental models,
such as those based on the distribution of 42K in ex-
perimental animals [4].
In the present study, external potassium balance
was manipulated (but not quantified) to produce dif-
ferences in plasma potassium concentration prior to
an acute potassium load (PK). Although the changes
in PK0 were rather small in magnitude, in each sub-
ject a higher PK was associated with a decrease in
both the rate and capacity of cellular potassium up-
take. This finding supports the observations of
Scribner and Burnell [11]. They estimated that in a
70-kg man, a fall in PK of 1 mEq/liter reflects a po-
tassium deficit of 100 to 200 mEq; most of the potas-
sium administered to repair this deficit would thus
be concentrated in cells (with an estimated apparent
volume of distribution of 1.5 to 3 liters/kg). In addi-
tion, the authors stated (unpublished observations)
that when normal potassium stores are exceeded, a
comparable increase in PK would be produced by a
smaller quantity of potassium. Our findings do not
contradict the phenomenon of extrarenal potassium
adaptation described by Alexander and Levinsky
[1]. These investigators found that rats chronically
fed a potassium-rich diet and then nephrectomized
demonstrated enhanced cellular uptake of an acute
potassium load in comparison to rats fed a regular
diet. As in our studies, prior to acute potassium
loading, PK (as well as tissue potassium) was lower
in the rats with enhanced cellular potassium uptake.
In addition, our studies in humans are consistent
with (I) evidence that cellular uptake of acute po-
tassium loads is enhanced in potassium-depleted
animals so that there is a lesser increment in PK for a
given load [12, 13]; and (2) in vitro tracer flux stud-
ies in red cells and in muscle which demonstrate
saturable potassium influx kinetics [14, 15].
The importance of endogenous insulin in promot-
ing cellular potassium uptake has recently been re-
viewed [16, 17]. As in insulin—deficient experimen-
tal animals [9, 18, 19], cellular uptake of an acute
potassium load was impaired in the single diabetic
subject studied, but only at higher levels of plasma
potassium concentration. Since there is both in vit-
ro and in vivo evidence that potassium directly
stimulates insulin secretion [16, 17, 19—23], it has
been suggested that the basis for decreased potas-
sium tolerance in diabetes is the absence of potas-
sium-induced increases in IRI [17]. In this study,
however, no increase in IRI was found in the non-
diabetic subjects. Similarly, in other studies of po-
tassium-infused normal human subjects, either no
increase [24, 25] or only a small increase [25] in IRI
has been found. Recently, cellular uptake of an
acute potassium load which did not increase IRI
was shown to be impaired in animals with low IRI
due to somatostatin [26]. Thus, endogenous insulin
might play a permissive rather than a regulatory
role in facilitating cellular potassium uptake [16].
The observations of the present study support that
view.
Our findings confirm the observations of Diuhy et
al [27], that aldosterone levels increase acutely in
response to potassium infusion. Whether this in-
crement in aldosterone levels is of any physiologic
significance in anuric subjects is, however, unclear.
In vitro observations have demonstrated that al-
dosterone stimulates muscle potassium loss (rather
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Appendix 3
Since aVD5 = V1 (1 + k1/k2), and (expressed as a percent of
R),
mx 100 X
k1-i-k2'
aVDk =
1 — Jmax/l00
The static parameters aVD1 and percent exit at 2 hours post-
infusion are similarly related.
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